药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Metacycline
Celiprolol
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Celiprolol.
Metacycline
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Farnesyl thiopyrophosphate.
Metacycline
Fleroxacin
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Fleroxacin.
Metacycline
Thiothixene
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Thiothixene.
Metacycline
Pheniramine
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Pheniramine.
Metacycline
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Lopinavir.
Metacycline
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lopinavir.
Metacycline
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Lopinavir.
Metacycline
Alimemazine
The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Lopinavir.
Metacycline
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Lopinavir.
Metacycline
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Lopinavir.
Metacycline
Desflurane
The risk or severity of QTc prolongation can be increased when Desflurane is combined with Lopinavir.
Metacycline
Cyclizine
The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Lopinavir.
Metacycline
Orphenadrine
The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Lopinavir.
Metacycline
Bretylium
The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lopinavir.
Metacycline
Levocabastine
The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Lopinavir.
Metacycline
Perhexiline
The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Lopinavir.
Metacycline
Mequitazine
The risk or severity of QTc prolongation can be increased when Mequitazine is combined with Lopinavir.
Metacycline
Gatifloxacin
The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lopinavir.
Metacycline
Felbamate
The risk or severity of QTc prolongation can be increased when Felbamate is combined with Lopinavir.